Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;35(6):467-483.
doi: 10.1521/aeap.2023.35.6.467.

"What Is the Benefit?": Perceptions and Preferences for Long-Acting Injectable Antiretroviral Therapy Among People Living With HIV

Humberto Rodriguez Gonzalez  1 , Andrea Isabel Volcan  2 , Breana Jae Uhrig Castonguay  2 , Jessica Carda-Auten  2 , Carolina Ruiz  1 , Matteo Peretti  3 , Angela Suarez  4 , Deanna Kerrigan  5 , David Alain Wohl  2 , Clare Barrington  1
Affiliations

"What Is the Benefit?": Perceptions and Preferences for Long-Acting Injectable Antiretroviral Therapy Among People Living With HIV

Humberto Rodriguez Gonzalez et al. AIDS Educ Prev. 2023 Dec.

Abstract

Long-acting injectable antiretroviral therapy (LA-ART) expands treatment options for people living with HIV (PLWH). This qualitative study characterizes LA-ART awareness, perceptions, and preferences among PLWH engaged in HIV care. From 2019 through 2021, we conducted semistructured in-depth interviews with 71 PLWH sampled from three clinics in three U.S. settings (North Carolina, Washington, DC, Massachusetts). Transcripts were analyzed using narrative and thematic techniques. Participant mean age was 46 years (range 24-72); most were cisgender men (55%) and virally suppressed (73%). Most participants had not heard of LA-ART and reacted with a mix of excitement and cautiousness. Potential LA-ART benefits included easier adherence, privacy, and effectiveness; concerns included effectiveness, side effects, costs, and increased clinic visits. Participants appreciated that LA-ART could support achieving and sustaining viral suppression. To inform their decision, participants wanted more information and convenient access and administration. Findings indicated that a shared decision-making approach and economic and logistical support for PLWH could facilitate LA-ART uptake.

Keywords: HIV; long-acting antiretroviral therapy; perceptions; viral suppression.

PubMed Disclaimer

References

    1. ACTG Network. (2022). A5359: The LATITUDE Study. Retrieved December 1, 2022, from https://actgnetwork.org/studies/a5359-the-latitude-study/
    1. Akinwunmi B, Buchenberger D, Scherzer J, Bode M, Rizzini P, Vecchio F, … Van de Velde N (2021). Factors associated with interest in a long-acting HIV regimen: Perspectives of people living with HIV and health-care providers in four European countries. Sexually Transmitted Infections, 97(8), 566–573. 10.1136/sextrans-2020-054648 - DOI - PubMed
    1. Broyles LN, Luo R, Boeras D, & Vojnov L (2023). The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: A systematic review. The Lancet, 402(10400), 464–471. 10.1016/S0140-6736(23)00877-2 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. (2022, September 2). Viral suppression. Retrieved October 25, 2022, from https://www.cdc.gov/hiv/statistics/overview/in-us/viral-suppression.html
    1. Christopoulos KA, Colasanti J, Johnson MO, Diaz Tsuzuki M, Erguera XA, Flores R, … McNulty MC (2022). Are patients and their providers talking about long-acting injectable antiretroviral therapy? Penetration into clinical encounters at three U.S. care sites. Open Forum Infectious Diseases, 9(7), ofac293. 10.1093/ofid/ofac293 - DOI - PMC - PubMed

Publication types

Substances